Cathepsin L interacts with CDK2‑AP1 as a potential predictor of prognosis in patients with breast cancer
Authors:
Open Access
- 7 November 2019
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 19 (1) , 167-176
Abstract
Cathepsin L (CTSL) is a lysosomal acid cysteine protease that has been implicated in tumorigenesis and malignant progression. In the present study, the role of CTSL in tumorigenesis and prognosis of breast cancer was evaluated. The prognostic value of CTSL was analyzed using immunohistochemistry in patients with breast cancer, as well as online microarray datasets. CTSL expression was knocked down in the breast cancer cell line T‑47D using RNA interference. MTT and colony formation assays were performed to assess the role of CTSL in the proliferation of breast cancer cells. Cell cycle progression and apoptosis were measured using flow cytometry. A physical interaction of CTSL and cyclin dependent kinase 2 associated protein 1 (CDK2‑AP1) was determined using a glutathione S‑transferase pull‑down assay. Endogenous CTSL expression was high in breast cancer cells and exhibited an inverse association with CDK2‑AP1 expression; aberrant expression of CTSL in breast cancer tissues predicted an improved clinical outcome and prognosis. In addition, CTSL knockdown decelerated the progression of breast cancer cells by arresting cell cycle progression and increasing apoptosis. Thus, CTSL may be a potential therapeutic target for treating patients with breast cancer.Keywords
This publication has 49 references indexed in Scilit:
- Triple-negative breast cancer: new perspectives for novel therapiesMedical Oncology, 2013
- Improving Breast Cancer Survival Analysis through Competition-Based Multidimensional ModelingPLOS Computational Biology, 2013
- MEROPS: the database of proteolytic enzymes, their substrates and inhibitorsNucleic Acids Research, 2011
- Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survivalBreast Cancer Research and Treatment, 2011
- Gene expression profiling of the tumor microenvironment during breast cancer progressionBreast Cancer Research, 2009
- Usefulness of Serum Cathepsin L as an Independent Biomarker in Patients With Coronary Heart DiseaseThe American Journal of Cardiology, 2009
- A Gene Expression Signature that Can Predict the Recurrence of Tamoxifen-Treated Primary Breast CancerClinical Cancer Research, 2008
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- Repeated observation of breast tumor subtypes in independent gene expression data setsProceedings of the National Academy of Sciences, 2003
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001